Alfena

Researchers are evaluating the C-mo System, a wearable device designed to automatically detect and describe cough events in patients aged 2 years and older who experience cough as a key or persistent symptom. The study aims to answer if the device can accurately identify coughs and analyze their intensity, type, and presence of wheezing. This clinical research is sponsored by Cough Monitoring Medical Solutions and focuses on cough-related conditions including asthma, COPD, gastroesophageal reflux, and idiopathic pulmonary fibrosis. Participants will wear the C-mo System device for 24 hours to monitor their coughs. During this period, they will also keep a diary of their activities and complete questionnaires about cough frequency, intensity, device usability, and how cough affects their quality of life. The study involves only one intervention group using the C-mo wearable device. Throughout the 24-hour monitoring, researchers will assess the accuracy of cough detection and characterization using various statistical measures. They will also evaluate wheezing detection and compare participants self-reported cough perception with expert evaluations. The study includes collecting data on cough patterns and intensity, as well as usability results of the device, providing detailed insights into cough monitoring and its impact during the study period.